Klaus Maleck is the Chief Financial Officer at ITM Isotope Technologies Munich SE, a radiopharmaceutical biotech firm. His extensive career spans over 25 years in the biopharmaceutical industry, including roles as CEO of TETEC AG and CFO at Evotec. He holds a PhD in Biochemistry and a masters degree in Biotechnology from ESBS Strasbourg.
Klaus is a board member of BIO Deutschland, the German biotechnology industry association. His career began in science as a researcher at Novartis before he moved into management consulting with McKinsey & Co. and later into corporate leadership, co-founding BioGeneriX AG.
He possesses a unique combination of a scientific background, including a PhD, and deep financial expertise, having led a NASDAQ listing and major corporate development.
Read the full overview →Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.